Pipeline Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference

Pipeline Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference




Pipeline Therapeutics to Present at the 21st Annual Virtual Needham Healthcare Conference

SAN DIEGO–(BUSINESS WIRE)–Pipeline Therapeutics, a clinical-stage biopharmaceutical company pioneering precision neuroregeneration, today announced that company management will present at the 21st Annual Virtual Needham Healthcare Conference, taking place from April 11-14, 2022. Carmine Stengone, Pipeline’s President and CEO, will present a company overview on April 13, 2022 at 4:30 pm ET. Company management will also participate in one-on-one meetings with investors during the conference.

About Pipeline Therapeutics

Pipeline Therapeutics is a clinical-stage biopharmaceutical company pioneering the development and commercialization of first-in-class therapies for precision neuroregeneration including myelin restoration, synaptogenesis and axonal repair. The Company has a broad pipeline of programs to address CNS and neuro-otology conditions. Its flagship program, PIPE-307, has completed a Phase 1 clinical trial in healthy volunteers and has received IND clearance from the FDA to initiate a Phase 1b/2a trial in relapsing-remitting MS patients. For more information, please visit www.pipelinetherapeutics.com and engage with us on LinkedIn.

Contacts

Company Contact:
Peter Slover

CFO

ir@pipeline-tx.com

Investor Contact:
Amy Conrad

858-914-1962

amy@juniper-point.com